A recent publication also identified site-specific phosphorylation changes in CSF along with the AD progression, particularly a reversal of pT181 at the onset of cognitive decline, which suggests sequestration in the brain of specific tau species [88]. This evidence concerns the gene MAPT and Alzheimer disease.